Management of Stuporous Patients

Introduction to Morphine Use

• The American College of Cardiology recommends morphine for stuporous patients with rigidity, as it provides potent analgesic effects, anxiolytic effects, and beneficial hemodynamic effects, including vasodilation and reduction of heart rate and systolic blood pressure 1
• Morphine can reduce myocardial oxygen demand in stuporous patients with rigidity, according to the American College of Cardiology 1
• The European Heart Journal suggests that morphine has anxiolytic effects, which can help reduce anxiety in stuporous patients with rigidity 2

Dosage and Administration

• The initial dose of morphine for stuporous patients with rigidity is 1-5 mg IV, as recommended by the American College of Cardiology and Circulation 1, 3, 4
• Morphine should be administered slowly, with careful monitoring of blood pressure, according to the American College of Cardiology 1
• The dose can be repeated every 5-30 minutes as needed to alleviate symptoms and maintain patient comfort, as suggested by the American College of Cardiology and Circulation 1, 4

Monitoring and Precautions

• Patients receiving morphine should be closely monitored for respiratory function, blood pressure, and level of consciousness, according to the American College of Cardiology 1
• The American College of Cardiology warns of the risk of hypotension, particularly in patients with volume depletion or concomitant vasodilator therapy 1, 4
• The European Heart Journal suggests considering alternative treatments, such as beta-blockers or intravenous nitrates, if opioids do not alleviate pain 2

Management of Adverse Effects

• Hypotension can be managed with positioning, fluid boluses, or atropine if bradycardia is present, according to the American College of Cardiology and Circulation 1, 4
• Respiratory depression can be treated with naloxone (0.4-2.0 mg IV), which should be available for immediate administration, as recommended by the American College of Cardiology and Circulation 1, 4
• Nausea and vomiting occur in approximately 20% of patients and can be managed with antiemetic prophylaxis, according to the American College of Cardiology and Circulation 1, 4

Safety and Efficacy

• A large observational registry (n=57,039 patients) showed an increased adjusted risk of death in patients who received morphine (adjusted OR=1.41; 95% CI: 1.26-1.57), as reported by the American College of Cardiology and Circulation 1, 5, 4
• The American Academy of Pediatrics recommends that the main signs of suffering in a stuporous patient include autonomic alterations such as tachycardia, hypertension, tachypnea, diaphoresis, facial grimacing, muscle rigidity, and limb movements that indicate pain or discomfort, even when the patient cannot communicate verbally 6, 7

Pain and Agitation Assessment

• The Critical Care Pain Observation Tool (CCPOT), Sedation-Agitation Score (SAS), Ramsay Agitation Sedation Scale (RASS), and Respiratory Distress Observation Scale (RDOS) are validated scales for evaluating pain, agitation, and respiratory distress in patients who cannot communicate verbally 7
• The Society for Critical Care Medicine recommends monitoring patients treated with antipsychotics for the characteristic triad of hyperthermia, muscle rigidity, and autonomic instability 6
• The American Thoracic Society notes that delirium can masquerade as pain and vice versa, and that agitation in patients with delirium can be the only sign of pain 8

Family Involvement and Support

• The Society of Critical Care Medicine recommends involving family members in the evaluation of suffering, as they can recognize subtle signs of discomfort in the patient, and allowing them to stay with the patient to provide emotional support 7

Neurological Signs and Conditions

• Asterixis, a neurological sign characterized by brief lapses in postural muscle tone, is a diagnostic criterion for overt hepatic encephalopathy, but can also be observed in other diseases such as uremia, hypercapnia, hypoglycemia, and effects of medications 9, 10, 11
• Asterixis can coexist with motor system anomalies and extrapyramidal dysfunction, and requires evaluation of underlying metabolic causes and treatment directed at the underlying condition, generally hepatic encephalopathy, with the asterixis usually being reversible with adequate treatment 9, 10, 11
• Distinguishing between asterixis and withdrawal tremor is crucial for proper management, as alcohol withdrawal tremor indicates the need for alcohol withdrawal management, typically with benzodiazepines 11, 12, 13